Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

Diabetes

Volumn 51, Issue 10, 2002, Pages 2944-2950

  Kelley, David E ^a   He, Jing ^a   Menshikova, Elizabeth V ^a   Ritov, Vladimir B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALAMETHICIN; ANTIBIOTIC AGENT; CITRATE SYNTHASE; CREATINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; ROTENONE;

ADULT; ARTICLE; BIOENERGY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RESPIRATORY CHAIN; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

EID: 0036788293     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.2944     Document Type: Article

References (51)

1. Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Theriault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705-2713, 1996
2. Kelley DE, Simoneau J-A: Impaired FFA utilization by skeletal muscle in NIDDM. J Clin Invest 94:2349-2356, 1994
3. Shulman GI, Rothman D, Jue T, Stein P, DeFronzo R, Shulman R: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
4. Blaak EE, Wagenmakers AJM, Glatz JFC, Wolffenbuttel BHR, Kemerink GJ, Langenberg CJM, Heidendal GAK, Saris WHM: Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol 279:146-154, 2000
5. Goodpaster BH, Theriault R, Watkins SC, Kelley DE: Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49:467-472, 1999
6. Simoneau J-A, Kelley DE: Altered skeletal muscle glycolytic and oxidative capacities contribute to insulin resistance in NIDDM. J Appl Physiol 83:166-171, 1997
7. Kelley DE, Mandarino LJ: Fuel selection in human skeletal muscle in insulin resistance. Diabetes 49:677-683, 2000
8. Schmitz-Peiffer C, Craig DL, Biden TJ: Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210, 1999
9. Gerbitz K-D, Gempel K, Brdiczka D: Mitochondria and diabetes: genetic, biochemical and clinical implications of the cellular energy circuit. Diabetes 45:113-126, 1996
10. Ritov VB, Gorbacheva LR, Tverdislova IL, Leikin IN, Bazhenov II: Rotenone-sensitive oxidation of NADH and F0F1-ATPase activity in a homogenate of rat skeletal muscles during thermal adaptation. Biokhimiia (Russian) 58:1779-1783, 1993
11. Grivennikova VG, Kapustin AN, Vinogradov AD: Catalytic activity of NADH-ubiquinone oxidoreductase (complex I) in intact mitochondria: evidence for the slow active/inactive transition. J Biol Chem 276:9038-9044, 2001
12. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
13. Frayn K: Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
14. Kelley D, Reilly J, Veneman T, Mandarino LJ: Effect of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 258:E923-E929, 1990
15. Kelley DE, Goodpaster BH, Wing RR, Simoneau J-A: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol 277:E1130-E1141, 1999
16. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36:914-924, 1987
17. Hother-Nielsen O, Henriksen JE, Staehr P, Beck-Nielsen H: Labelled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important? Am J Physiol Endocrinol Metab 2:275-287, 1995
18. Robinson DG, Ehlers U, Herken R, Herrman B, Mayer F, Schurmann FW: Methods of Preparation for Electron Microscopy: An Introduction for the Biomedical Sciences. Tokyo, Springer-Verlag, 1987
19. Reynolds ES: The use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 17:208-212, 1963
20. Haggis GH: The Electron Microscope in Molecular Biology. William London, Glowes and Sons, Longmans, 1966
21. Ritov VB, Kelley DE: Hexokinase isozyme distribution in human skeletal muscle. Diabetes 50:1253-1262, 2001
22. Rasmussen HN, Andersen AJ, Rasmussen UF: Optimization of preparation of mitochondria from 25-100 mg skeletal muscle. Anal Biochem 252:153-159, 1998
23. He J, Watkins S, Kelley DE: Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-823, 2001
24. Colberg S, Simoneau J-A, Thaete FL, Kelley DE: Impaired FFA utilization by skeletal muscle in women with visceral obesity. J Clin Invest 95:1846-1853, 1995
25. Pessah IN, Francini AO, Scales DJ, Waterhouse AL, Casida JE: Calcium-ryanodine receptor complex: solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles. J Biol Chem 261:8643-8648, 1986
26. Vinogradov AD, King TE: The Keilin-Hartree heart muscle preparation. Methods Enzymol 55:118-127, 1979
27. Langmuir ME, Yang J, Moussa AM, Laura R, LeCompte KA: New naphthopyranone based fluorescent thiol probes. Tetrahedron Lett 36:3989-3992, 1995
28. Pesce AJ, Kaplan LA, Pesce AJ, Kaplan LA (Eds.): Methods in Clinical Chemistry. St. Louis, MO, CV Mosby, 1987
29. Chi M-Y, Hintz CS, Coyle EF, Martin WH 3rd, Ivy JL, Nemeth PM, Holloszy JO, Lowry OH: Effects of detraining on enzymes of energy metabolism in individual human muscle fibers. Am J Physiol 244:C276-C287, 1983
30. Simoneau J-A, Veerkamp JH, Turcotte LP, Kelley DE: Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051-2060, 1999
31. Kruszynska YE, Mulford MI, Baloga J, Yu JG, Olefsky JM: Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Diabetes 47:1107-1113, 1998
32. Bass A, Vondra K, Rath R, Vitek V, Havaranck T: Metabolic changes in the quadriceps femoris muscle of obese people: enzyme activity patterns of energy-supplying metabolism. Pflugers Archives 359:325-334, 1975
33. Lithell H, Lindgarde F, Hellsing K, Lundqvist G, Nygaard E, Vessby B, Saltin B: Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentrations and glucose tolerance in 48-year-old men. Diabetes 30:19-25, 1981
34. Vodra K, Rath R, Bass A, Slabochova Z, Teisinger J, Vitek V: Enzyme activities in quadriceps femoris muscle of obese diabetic male patients. Diabetologia 13:527-529, 1977
35. Vogel H: Mitochondrial myopathies and the role of the pathologist in the molecular era. J Neuropathol Exp Neurol 60:217-227, 2001
36. Saraste M: Oxidative phosphorylation at the fin de siecle. Science 283: 1488-1492, 1999
37. Ritov VB, Tverdislova IL, Avakyan TY, Menshikova EV, Leikin YN, Bratkovskaya LB, Shimon RG: Alamethicin-induced pore formation in biological membranes. Gen Physiol Biophys 11:49-58, 1992
38. Eisenberg BR: Quantitative ultrastructure of mammalian skeletal muscle. In Handbook of Physiology: Vol. 10: Skeletal Muscle. Peachey LD, Ed. Bethesda, MD, American Physiological Society, 1983, p. 73-112
39. Jerusalem F, Engel AG, Peterson HA: Human muscle fiber fine structure: morphometric data on controls. Neurology 25:127-134, 1975
40. Ogata T, Yamasaki Y: Ultra-high-resolution scaning electron microscopy of mitochondria and sarcoplasmic reticulum arrangement in human red, white and intermediate muscle fibers. Anat Rec 248:216-223, 1997
41. Finley BE, Norton S: Effects of hyperglycemia on mitochondrial morphology in the region of the anterior neuropore in the explanted rat embryo model: evidence for a modified Reid hypothesis as a mechanism for diabetic teratogenesis. Am J Obstet Gynecol 165:1661-1665, 1991
42. Horton WE Jr, Sadler TW: itochondrial alterations in embryos exposed to B-hydroxybutyrate in whole embryo culture. Anat Rec 213:94-101, 1985
43. Yang X, Borg LA, Eriksson UJ: Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anat Rec 241:255-267, 1995
44. Beutner G, Ruck A, Riede B, Brdiczka D: Complexes between hexokinase, mitochondrial porin and adenylate translocator in brain: regulation of hexokinae, oxidative phosphorylation and permeability transition pore. Biochem Soc Trans 25:151-157, 1997
45. Essig DA: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. Exerc Sport Sci Rev 24:289-319, 1996
46. Ames BN, Shigenaga MK, Hagen TM: Mitochondrial decay in aging. Biochimica Biophysica Acta 1271:165-170, 1995
47. Basu S, Bayoumi S, Zhang Y, Lozano J, Kolesnick R: BAD enables ceramide to signal apoptosis via ras and raf-1. J Biol Chem 273:30419-30426, 1998
48. Papa S: Mitochondrial oxidative phosphorylation changes in the life span: molecular aspects and physiopathological implications. Biochimica Biophysica Acta 1276:87-105, 1996
49. Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, Horton T, Jun AS, Lott MT: Mitochondrial DNA mutations in human degenerative diseases and aging. Biochimica Biophysica Acta 1271:141-151, 1995
50. Liang P, Hughes V, Fukagwa NK: Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance. Diabetes 46:920-923, 1997
51. Nishikawa T, Edelstein D, Du X-L, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates P, Hammes H-P, Giardino I, Brownlee M: Normalizing mitochondria superoxide production blocks three pathways of hyperglycemic damage. Nature 404:787-790, 2000